GPT ELISA Kit

  • Check with publisher
  • Published date: June 28, 2018
    • Shirley, New York , United States

Mouse Glutamic Pyruvic Transaminase ELISA Kit kit is a 1.5 hour solid-phase ELISA designed for the quantitative determination of the Glutamic Pyruvic Transaminase. This ELISA kit is for research use only, not for therapeutic or diagnostic applications.

Result 0 votes
Thomas Schmitt
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Magic™ Humanized PD-1 Immune Checkpoint Knock-In Mice

    Magic™ Humanized PD-1 Immune Checkpoint Knock-In Mice

    Biology & Physiology Shirley (New York) September 30, 2019 Check with publisher

    Management of cancer is a big problem, not only because the difficulties in developing new drugs but also because tumor cells usually acquire resistance to anti-cancer drugs to avoid immune destruction (immune escape). One of the most important mecha...

  • Magic™ Humanized LAG3 Immune Checkpoint Knock-In Mice

    Magic™ Humanized LAG3 Immune Checkpoint Knock-In Mice

    Biology & Physiology Shirley (New York) September 30, 2019 Check with publisher

    Recent achievements in cancer immunotherapy especially immune checkpoint modulators are reshaping the way of conventional cancer treatment. Nowadays, the rapid development of immune checkpoint targeting drugs has become one of the hotspots that are a...

  • Magic™ Humanized OX40 Immune Checkpoint Knock-In Mice

    Magic™ Humanized OX40 Immune Checkpoint Knock-In Mice

    Biology & Physiology Shirley (New York) September 30, 2019 Check with publisher

    Administration of anti-OX40 increases proliferation of peripheral blood CD4+ and CD8+ T cells, increases responses to recall and naïve reporter Ags, and increases endogenous tumor-specific immune responses. Several agonistic anti-OX40 antibodies are ...